Literature DB >> 17640776

Construction and immunogenicity of recombinant adenovirus expressing the major outer membrane protein (MOMP) of Chlamydophila psittaci in chicks.

Jizhang Zhou1, Changqing Qiu, Xiao-An Cao, Guozhen Lin.   

Abstract

Avian chlamydiosis is caused by Chlamydophila psittaci. The major outer membrane protein (MOMP) encoded by the outer membrane protein 1 (omp1) gene is an excellent candidate for genetic engineering of a vaccine against avian chlamydiosis. In this study, the MOMP gene was amplified by PCR and cloned into the transfer vector pShuttle-CMV. The recombinant plasmid was obtained by recombination between the plasmid pShuttle-CMV-MOMP and skeleton vector pAdEasy-1 in Escherichia coli strain BJ5183. The titer of recombinant adenovirus containing the MOMP gene (rAd-MOMP) of C. psittaci was 3.4x10(10)TCID(50)/ml in human embryonic kidney 293 (HEK293) monolayer cells. The expression of the MOMP in HEK293 cells infected with rAd-MOMP was confirmed by an indirect immunofluorescence assay. Specific pathogen free (SPF) chicks were inoculated with 10(6), 10(8), and 10(10)TCID(50) of rAd-MOMP/chick. Inoculated chicks generated antibodies against MOMP of C. psittaci, which were detected by an indirect hemagglutination test (IHA). The vaccinated chicks were challenged with a virulent Chinese field isolate. Nine out of 10 chicks in the vaccinated group were protected, while birds in the wild-type adenovirus control group and the PBS control group all showed clinical signs after challenge. The results indicate that the recombinant adenovirus containing the MOMP gene of C. psittaci might be a candidate vaccine against avian chlamydiosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17640776     DOI: 10.1016/j.vaccine.2007.06.031

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  9 in total

1.  Immunization trials with an avian chlamydial MOMP gene recombinant adenovirus.

Authors:  Changqing Qiu; Jizhang Zhou; Xiao-an Cao; Guozhen Lin; Fuying Zheng; Xiaowei Gong
Journal:  Bioeng Bugs       Date:  2010-03-12

2.  Combating chlamydiosis.

Authors:  Helen O'Shea
Journal:  Bioeng Bugs       Date:  2010 Jul-Aug

Review 3.  Chlamydial polymorphic membrane proteins: regulation, function and potential vaccine candidates.

Authors:  Sam Vasilevsky; Milos Stojanov; Gilbert Greub; David Baud
Journal:  Virulence       Date:  2015-11-18       Impact factor: 5.882

4.  Simultaneous Intramuscular And Intranasal Administration Of Chitosan Nanoparticles-Adjuvanted Chlamydia Vaccine Elicits Elevated Protective Responses In The Lung.

Authors:  Yumeng Li; Chuan Wang; Zhenjie Sun; Jian Xiao; Xiaoliang Yan; Yuqing Chen; Jian Yu; Yimou Wu
Journal:  Int J Nanomedicine       Date:  2019-10-08

5.  Intranasal immunization with inactivated chlamydial elementary bodies formulated in VCG-chitosan nanoparticles induces robust immunity against intranasal Chlamydia psittaci challenge.

Authors:  Zonghui Zuo; Yongjuan Zou; Qiang Li; Yongxia Guo; Tianyuan Zhang; Jie Wu; Cheng He; Francis O Eko
Journal:  Sci Rep       Date:  2021-05-17       Impact factor: 4.379

6.  Construction of Recombinant HVT Expressing PmpD, and Immunological Evaluation against Chlamydia psittaci and Marek's Disease Virus.

Authors:  Shanshan Liu; Wei Sun; Jun Chu; Xiufen Huang; Zongxue Wu; Minxin Yan; Qiang Zhang; Peng Zhao; Joseph U Igietseme; Carolyn M Black; Cheng He; Yongqing Li
Journal:  PLoS One       Date:  2015-04-20       Impact factor: 3.240

7.  A Promising Recombinant Herpesvirus of Turkeys Vaccine Expressing PmpD-N of Chlamydia psittaci Based on Elongation Factor-1 Alpha Promoter.

Authors:  Shanshan Liu; Wei Sun; Xuefei Huang; Wen Zhang; Changqing Jia; Jie Luo; Yihua Shen; Saeed El-Ashram; Cheng He
Journal:  Front Vet Sci       Date:  2017-12-14

8.  Prevalence, Diagnosis, and Vaccination Situation of Animal Chlamydiosis in China.

Authors:  Jizhang Zhou; Zhaocai Li; Zhongzi Lou; Yuanyuan Fei
Journal:  Front Vet Sci       Date:  2018-05-30

9.  Cellular Basis for the Enhanced Efficacy of the Fms-Like Tyrosine Kinase 3 Ligand (FL) Adjuvanted VCG-Based Chlamydia abortus Vaccine.

Authors:  Shakyra Richardson; Fnu Medhavi; Tayhlor Tanner; Stephanie Lundy; Yusuf Omosun; Joseph U Igietseme; Darin Carroll; Francis O Eko
Journal:  Front Immunol       Date:  2021-06-24       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.